Randomised controlled trial of treating dysfunctional breathing to reduce breathlessness in severe asthma
ISRCTN | ISRCTN92818360 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN92818360 |
Secondary identifying numbers | N0226167744 |
- Submission date
- 29/09/2006
- Registration date
- 29/09/2006
- Last edited
- 12/05/2017
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Rob Niven
Scientific
Scientific
North West Lung Centre
South Manchester University Hospitals NHS Trust
Wythenshawe Hospital
Southmoor Road
Manchester
M23 9LT
United Kingdom
Phone | +44 (0)161 291 2846 |
---|---|
Robert.Niven@smuht.nwest.nhs.uk |
Study information
Study design | Randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Not specified |
Study type | Treatment |
Scientific title | Randomised controlled trial of treating dysfunctional breathing to reduce breathlessness in severe asthma |
Study objectives | To improve thoraco-abdominal co-ordination and hence reduce breathlessness. |
Ethics approval(s) | Not provided at time of registration |
Health condition(s) or problem(s) studied | Respiratory: Asthma |
Intervention | 1. Patients will undergo breathing retraining with senior physiotherapist 2. Control |
Intervention type | Other |
Primary outcome measure | Change in University of California San Diego Shortness-of-Breath Questionnaire (SOBQ) score after treatment for dysfunctional breathing |
Secondary outcome measures | Not provided at time of registration |
Overall study start date | 06/04/2004 |
Completion date | 15/12/2005 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Sex | Both |
Target number of participants | 31 |
Key inclusion criteria | 31 patients suffering from severe asthma: 1. Patients with diagnosis of asthma requiring regular maintenance medication (that includes high dose inhaled corticosteroid and long-acting Β2 agonist) 2. High medical resource usage 3. Non-smoker for at least one year 4. Historical evidence of reversibility |
Key exclusion criteria | 1. Previous treatment for hyperventilation, dysfunctional breathing, or other functional disorder of respiratory mechanics 2. Participation in another trial involving respiratory intervention 3. Current or recent lower respiratory tract infection 4. Presence of other respiratory diseases 5. DLCO <70% predicted, significant co-morbid illness 6. Pregnancy or nursing mother 7. Psychiatric disorder 8. Hospitalisation for asthma within the prior 6 weeks |
Date of first enrolment | 06/04/2004 |
Date of final enrolment | 15/12/2005 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
North West Lung Centre
Manchester
M23 9LT
United Kingdom
M23 9LT
United Kingdom
Sponsor information
Record Provided by the NHSTCT Register - 2006 Update - Department of Health
Government
Government
The Department of Health
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
Phone | +44 (0)20 7307 2622 |
---|---|
dhmail@doh.gsi.org.uk | |
Website | http://www.dh.gov.uk/Home/fs/en |
Funders
Funder type
Government
South Manchester University Hospitals NHS Trust (UK) NHS R&D Support Funding
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |